Gland Pharma Ltd (543245) Stock Price & News

543245:BOM

Gland Pharma Ltd

₹2,963.10

-0.37%

(-10.95) 1D

Sep 8, 3:30:00 PM GMT+5:30 · INR

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 543245...

Open

₹3,038.95

High

₹3,038.95

Low

₹2,903.30

Mkt. cap

487.48B

Avg. vol.

0.00

Volume

104.29K

Dividend

0.67%

Quarterly dividend

₹5.00

Ex-dividend date

Aug 11, 2026

P/E ratio

43.33

52-wk high

₹3,041.95

52-wk low

₹1,575.00

EPS

₹68.39

No. of employees

Open

₹3,038.95

High

₹3,038.95

Low

₹2,903.30

Mkt. cap

487.48B

Avg. vol.

0.00

Volume

104.29K

Dividend

0.67%

Quarterly dividend

₹5.00

Ex-dividend date

Aug 11, 2026

P/E ratio

43.33

52-wk high

₹3,041.95

52-wk low

₹1,575.00

EPS

₹68.39

No. of employees

News stories

From web sources and news partners

BigGo Finance

1 day ago

Fosun Pharma Sells Gland Pharma Stake for ₹27.996 Billion to Fund H-Share Buyback

Moomoo

1 day ago

Hong Kong Stock Market Movers | Fosun Pharma (02196) rises over 5% in early trading after controlling subsidiary sells approximately 6.00% stake in Gland Pharma for INR 27.996 billion

TradingView

2 days ago

Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln

About Gland Pharma Ltd

CEOShyamakant Giri

Employees4.33K

Founded1978

Headquarters-

SectorPharmaceutical industry

Websiteglandpharma.com

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	14.87B	16.95B	17.43B	18.00B
Cost of goods sold	6.04B	6.31B	8.32B	6.80B
Cost of revenue	6.04B	6.31B	8.32B	6.80B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.85B	4.24B	4.26B	4.44B
Operating expense	6.75B	7.37B	5.22B	7.42B
Total operating expenses	12.79B	13.68B	13.54B	14.22B
Operating income	2.08B	3.27B	3.89B	3.78B
Other non operating income	841.62M	631.73M	-1.79B	612.28M
EBT including unusual items	2.84B	3.62B	5.06B	4.35B
EBT excluding unusual items	2.84B	3.86B	5.02B	4.35B
Income tax expense	1.00B	1.01B	1.39B	1.18B
Effective tax rate	35.30%	27.79%	27.51%	27.13%
Other operating expenses	1.84B	2.06B	-130.22M	1.87B
Net income	1.84B	2.61B	3.67B	3.17B
Net profit margin	12.35%	15.42%	21.04%	17.61%
Earnings per share	11.15	16.98	22.23	19.22
Interest and investment income	-	-	2.06B	-
Interest expense	-78.23M	-39.30M	-63.09M	-43.61M
Net interest expenses	-78.23M	-39.30M	1.99B	-43.61M
Depreciation and amortization charges	1.06B	1.08B	1.09B	1.11B
EBITDA	3.11B	4.17B	4.91B	4.80B
Gain or loss from assets sale	-	-	-	-

Ask anything